Trading Halt
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Adherium Ltd. has requested a trading halt for its securities pending an announcement regarding a proposed capital raising. The halt will remain in effect until normal trading resumes or the announcement is released to the market. The company has confirmed there are no other matters that need to be disclosed at this time.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
On 6ix: 6ix.com/news/trading-halt-1215
In the deck
Earlier from Adherium
- Quarterly Activities/Appendix 4C Cash Flow Report
- Adherium exceeds CY2025 device shipment milestones
- Adherium quarter to date sales update
- Adherium reaches major milestone in Allergy Partners rollout
- Adherium's Hailie® Smartinhaler® Chosen for Groundbreaking iCARE Study: Significant Adherence, Consistent Outcomes, and Global Health System Savings
Later from Adherium
- Equity Raising Investor Presentation
- Placement and Accelerated Non-Renounceable Entitlement Offer
- Completion of Placement and Institutional Entitlement Offer
- Half Yearly Report and Accounts
- Adherium Hailie Smartinhaler Quarter-to-Date Sales Update
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium